DreamCIS, Inc. (KOSDAQ:223250)
South Korea · Delayed Price · Currency is KRW 3,395.00
+95.00 (2.88%)
At close: Sep 4, 2026
DreamCIS Market Cap
DreamCIS has a market cap or net worth of 83.52 billion as of September 4, 2026. Its market cap has increased by 0.27% in one year.
Market Cap
83.52B
Enterprise Value
72.88B
Revenue
73.28B
Ranking
n/a
PE Ratio
277.73
Stock Price
3,395.00
ChartMarket Cap Chart
Since May 22, 2020, DreamCIS's market cap has decreased from 165.28B to 83.52B, a decrease of -49.47%. That is a compound annual growth rate of -10.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 83.52B | -45.00% |
| Dec 30, 2025 | 151.84B | 116.27% |
| Dec 30, 2024 | 70.21B | -9.03% |
| Dec 28, 2023 | 77.17B | 25.17% |
| Dec 29, 2022 | 61.65B | -15.87% |
| Dec 30, 2021 | 73.28B | -32.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ingenia Therapeutics | 953.79B |
| Penetrium Bioscience | 271.08B |
| P&K Skin Research Center | 52.77B |
| HLB bioStep | 41.91B |
| Kolmar BioTech | 36.86B |
| SLS BIO | 26.89B |
| C&R Research | 22.79B |
| DT&CRO CO. | 19.82B |